pancreatic%20cancer
PANCREATIC CANCER
Pancreatic cancer is malignancy arising from the pancreas.
It is the 13th most common cancer in the world, 10th most common in the United States, and 4th leading cause of cancer-related deaths in the United Stated and Europe.
Exocrine tumors account for 95% of malignant pancreatic disease.
It is more common in women.
The median age of occurrence is at 71 years old.

Signs and Symptoms

  • Jaundice
    • Common in patients w/ malignancy in the head of the pancreas
  • Abdominal pain
    • Common in patients w/ tumors located in the body and tail of the pancreas
  • Weight loss
  • Back pain
  • Symptoms secondary to compression caused by the tumor:
    • Nausea/vomiting
    • Anorexia
    • Dyspepsia
    • Gastrointestinal bleeding
  • Symptoms caused by biliary obstruction:
    • Dark urine
    • Lightly colored-grayish stool
    • Pruritus
    • Infections (cholangitis, pancreatitis)
    • Scleral icterus
  • Symptoms caused by pancreatic enzyme insufficiency:
    • Malabsorption
    • Fatty stools
    • Increased flatulence
    • Ascites

Risk Factors

High Risk:
  • Familial atypical multiple-mole melanoma (FAMMM)
  • Hereditary pancreatitis
  • Peutz-Jeghers syndrome
  • >3 1st-degree relatives diagnosed w/ pancreatic cancer
Moderate Risk:
  • 2 1st-degree relatives diagnosed w/ pancreatic cancer
  • Cystic fibrosis
  • Chronic pancreatitis
  • BRCA2 mutation carrier
  • PALB2 mutation carrier
Low Risk:
  • Cigarette smoking
  • Diabetes mellitus (DM)
  • Obesity/Increased body mass index (BMI)
  • Occupational exposure to chemicals (eg beta-naphthylamine, benzidine)
  • Heavy alcohol consumption
  • One 1st-degree relative diagnosed w/ pancreatic cancer
  • Increased consumption of red/processed meat and dairy products
  • Low intake of fruits & vegetables
  • Low plasma 25-hydroxyvitamin D levels
  • History of gallstones & H. pylori infection
  • BRCA1 mutation carrier
  • Familial adenomatous polyposis
  • Li-Fraumeni syndrome
  • Lynch syndrome
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
27 Jan 2018
There is an over-representation of women in published reports of celecoxib drug-induced liver injury (DILI), according to a recent study. Latency has been shown to be short (<3 months) in most patients, but some of them may present with DILI after prolonged use of celecoxib.
22 Mar 2016
A recent study showed that routine use of alpha galactosidase (AG) has no benefit in irritable bowel syndrome (IBS) patients.
15 Nov 2017
Both hatha yoga and a low-FODMAP (Fermentable, Oligo-, Di-, Monosaccharides and Polyol) diet can alleviate gastrointestinal symptoms, as well as improve a range of other psychological and physiological health parameters, in patients with irritable bowel syndrome (IBS), a study has shown.
Rachel Soon, 14 Dec 2016

More well-designed studies are needed to confirm the benefits of various probiotics currently promoted for gut health, according to experts.